| Unique ID issued by UMIN | UMIN000058675 |
|---|---|
| Receipt number | R000066944 |
| Scientific Title | Assessment of Pericoronary Adipose Tissue Attenuation and Its Diagnostic Utility in Coronary Microvascular Dysfunction |
| Date of disclosure of the study information | 2025/12/01 |
| Last modified on | 2025/08/09 20:17:55 |
Assessment of Pericoronary Adipose Tissue Attenuation and Its Diagnostic Utility in Coronary Microvascular Dysfunction
Assessment of Pericoronary Adipose Tissue Attenuation and Its Diagnostic Utility in Coronary Microvascular Dysfunction
Assessment of Pericoronary Adipose Tissue Attenuation and Its Diagnostic Utility in Coronary Microvascular Dysfunction
Assessment of Pericoronary Adipose Tissue Attenuation and Its Diagnostic Utility in Coronary Microvascular Dysfunction
| Japan |
coronary microvascular dysfunction
| Cardiology |
Others
NO
To assess the association between CT value attenuation of pericoronary adipose tissue assessed using coronary CT and coronary microcirculatory impairment.
Efficacy
Exploratory
Diagnosis of coronary microcirculatory impairment by attenuation of CT values of pericoronary adipose tissue measured by coronary CT within 120 days before and after a coronary angiography procedure.
Observational
| 18 | years-old | <= |
| Not applicable |
Male and Female
(i) Patients with ischaemic symptoms such as chest pain and no obvious significant stenosis (>50%) on coronary angiography
(ii) Patients who have undergone invasive coronary function assessment (CFR and IMR) using a pressure wire
(iii) Patients who have undergone coronary computed tomography angiography within 120 days before or after coronary angiography
(iv) Patients aged 20 years or over who are eligible for consent
(i) Patients with >=50% stenosis or occlusive lesion in any of the three branches or side branches with a vessel diameter of >=1.5 mm or fractional flow reserve (FFR) <=0.8 at coronary angiography
(ii) Patients with a history of acute coronary syndrome
(iii) Patients who have undergone revascularisation (percutaneous coronary intervention, coronary artery bypass grafting) in the past
(iv) Patients with suspected hypertrophic cardiomyopathy, cardiac amyloidosis, or Fabry's disease
(v) Patients with moderate or severe valvular disease
(vi) Patients undergoing coronary perfusion assessment after cardiac surgery or percutaneous coronary intervention
(vii) Patients with inadequate quality of coronary computed tomography angiography images and inability to assess PCAT attenuation
(viii) Patients who refused to participate in the study
150
| 1st name | Takayoshi |
| Middle name | |
| Last name | Toba |
Kobe University Hospital
Department of Internal Medicine
650-0017
7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, Japan
078-382-5846
taka0222@med.kobe-u.ac.jp
| 1st name | Takayoshi |
| Middle name | |
| Last name | Toba |
Kobe University Hospital
Department of Internal Medicine
650-0017
7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, Japan
078-382-5846
taka0222@med.kobe-u.ac.jp
Kobe University Hospital
Takayoshi Toba
None
Self funding
the Ethics Committee of Kobe University Hospital
7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, Japan
078-382-5846
kansatsu@med.kobe-u.ac.jp
NO
| 2025 | Year | 12 | Month | 01 | Day |
Unpublished
Preinitiation
| 2025 | Year | 08 | Month | 01 | Day |
| 2025 | Year | 08 | Month | 01 | Day |
| 2028 | Year | 03 | Month | 31 | Day |
None
| 2025 | Year | 08 | Month | 02 | Day |
| 2025 | Year | 08 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000066944